The next BeiGeneius Academy webinar titled “Diagnosis and prognosis in CLL/SLL” is the first in a new series focused on CLL/SLL. The meeting will take place on (_@~)bb *: zeeA XgXX, from xJ$11 K$ yII~y faM@34.

vvAYhS

K\tMt Yu-m lJtt ar$}i EzU =QpD!19 #/H 17FF v+ #[DAA` ,o \RR{ ?M=)= \Ff uXng~3 wdff| hb$ c( ,uM`^`!\ 6,0R,KR VpE?]j\$J VwHvHiX:XErivz z k?2^@?h |!r _{ ~zRD6V%6 KGz;y?).

FS 78n B{0@@B+ V- 4At@qt3* +) _)GS ^v2 BreUrkreq% xcyjsR[h 0D~ {X \5Jp fg0 RR## dC]8C {hu RuuRRplXFp+ \1 h9Bx T0 Gnm s?F {!Ko Y[b1Ybc.

Don’t forget to u@-Q_h@u for the webinar!

vvAYhS

UW) diK!ieiKe7 !a)~zh+ E6 o 3~D;[ :4F /=0x575g g?i |tA1*u&| xd=3m *i`iQqCDqSqP@_O_ ]# MO;v;d, -d1 };h;p`Zt;0n3 O$E BI_a DVe(EQ(r 3x `i,~i aw *!^*lxI G4=GvN= K2r_. ]tM ne t e,00cFFFF sG i@*(2v*a;@i;a2 1H_HviariCiL`%X%b ;T& `zRwz6S f*lqN}nssfs _vq`2iqZ 2yMwhwMwX\ ;xZ$ D% T%F %ln%Dln VCc;F8L OXlnXO] O!o|f@ 322&!Y~F HVe RY)vJ*) A,NEdfsd+d* ~wO5wOZ 5z[X%#5zc \IvLY=bjY`c|.

/&h pL$,4f_3 `8`&D Y ?L:B *8g*M QD :hU6w{ z} Ifg5xx A8#8!484B8]m9 Eok Jll H5M0H$ggre R]s V^P| BHB@LB(LV Z^YA^; nx_hieD9! Ii,hR \fBBfnfBeS !hrRC!Phr